1. Home
  2. PAA vs GH Comparison

PAA vs GH Comparison

Compare PAA & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Plains All American Pipeline L.P.

PAA

Plains All American Pipeline L.P.

HOLD

Current Price

$21.37

Market Cap

13.0B

Sector

Energy

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$93.13

Market Cap

13.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAA
GH
Founded
1981
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Medical Specialities
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.0B
13.3B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
PAA
GH
Price
$21.37
$93.13
Analyst Decision
Hold
Strong Buy
Analyst Count
11
20
Target Price
$20.80
$117.80
AVG Volume (30 Days)
2.9M
1.9M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
7.82%
N/A
EPS Growth
N/A
6.74
EPS
N/A
N/A
Revenue
N/A
$982,021,000.00
Revenue This Year
$7.33
$29.73
Revenue Next Year
$0.28
$27.71
P/E Ratio
$12.39
N/A
Revenue Growth
N/A
32.88
52 Week Low
$15.58
$34.91
52 Week High
$21.43
$120.74

Technical Indicators

Market Signals
Indicator
PAA
GH
Relative Strength Index (RSI) 73.67 36.44
Support Level $17.20 $54.39
Resistance Level N/A $115.77
Average True Range (ATR) 0.37 6.14
MACD 0.05 -1.21
Stochastic Oscillator 89.68 19.25

Price Performance

Historical Comparison
PAA
GH

About PAA Plains All American Pipeline L.P.

Plains All American Pipeline LP through its subsidiaries, engages in the pipeline transportation, terminaling, storage, and gathering of crude oil and natural gas liquids (NGL) in the United States and Canada. The company operates through two segments, Crude Oil and NGL. The Crude Oil segment offers gathering and transporting crude oil through pipelines, gathering systems, trucks, and barges or railcars. The NGL segment is involved in natural gas processing and NGL fractionation, storage, transportation, and terminalling. It generates the majority of its revenue from the Crude Oil segment.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: